Eustachian tube dysfunction (ETD) is a common condition affecting both children and adults. Selecting the appropriate management strategy requires identifying the root cause driving the dysfunction.
Current evidence indicates that no medications have been shown to improve patient-oriented outcomes in ETD. Treatment is therefore directed toward addressing the underlying cause of the dysfunction, with systemic decongestants considered in select cases.
The structured protocol outlines a cause-directed management strategy. A specific category of pharmacological support may be appropriate in isolated presentations — the complete regimen, decision criteria, and sequencing are detailed in the full protocol.